Reply: Long-Term Efficacy and Safety of Polyacrylamide Hydrogel Injection in the Treatment of Human Immunodeficiency Virus-Related Facial Lipoatrophy

被引：0
|
作者：
Pignatti, Marco [1 ]
De Santis, Giorgio [1 ]
机构：
[1] Univ Modena & Reggio Emilia, Policlin Modena, Dept Plast & Reconstruct Surg, Modena, Italy
来源：
PLASTIC AND RECONSTRUCTIVE SURGERY | 2012年 / 130卷 / 01期
关键词：
D O I：
10.1097/PRS.0b013e318254b639
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：177E / 178E
页数：3
相关论文
共 50 条
  • [1] Long-Term Efficacy and Safety of Polyacrylamide Hydrogel Injection in the Treatment of Human Immunodeficiency Virus-Related Facial Lipoatrophy
    Long, Xiao
    Wang, Xiaojun
    Wang, Yang
    Zhao, Ru
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2012, 130 (01) : 176E - 177E
  • [2] Long-Term Efficacy and Safety of Polyacrylamide Hydrogel Injection in the Treatment of Human Immunodeficiency Virus-Related Facial Lipoatrophy: A 5-Year Follow-Up
    De Santis, Giorgio
    Pignatti, Marco
    Baccarani, Alessio
    Pedone, Antonio
    Spaggiari, Antonio
    Orlando, Gabriella
    Guaraldi, Giovanni
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2012, 129 (01) : 101 - 109
  • [3] Polyacrylamide hydrogel injection in the management of human immunodeficiency virus-related facial lipoatrophy: A 2-year clinical experience
    De Santis, Giorgio
    Jacob, Vinay
    Baccarani, Alessio
    Pedone, Antonio
    Pinelli, Massimo
    Spaggiari, Antonio
    Guaraldi, Giovanni
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2008, 121 (02) : 644 - 653
  • [4] Polyacrylamide Hydrogel Injection in the Management of Human Immunodeficiency Virus-Related Facial Lipoatrophy: Results of the LIPOPHILL Open-Label Study
    Mole, Bernard
    Gillaizeau, Florence
    Carbonnel, Elisabeth
    Pierre, Isabelle
    Brazille, Patricia
    Grataloup, Christine
    Mercier, Sylvie
    Duracinsky, Martin
    Weiss, Laurence
    Piketty, Christophe
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2012, 28 (03) : 251 - 258
  • [5] Long-term safety and efficacy of eutrophill for treatment of HIV-associated facial lipoatrophy
    Carbonnel, E.
    Mole, B.
    Kazatchkine, M.
    Claudy, A.
    ANTIVIRAL THERAPY, 2006, 11 (07) : L60 - L60
  • [6] Safety and Efficacy of One-Step Rehabilitation of Human Immunodeficiency Virus-Related Facial Lipoatrophy Using an Injectable Calcium Hydroxylapatite Dermal Filler
    Rauso, Raffaele
    Curinga, Giuseppe
    Rusciani, Antonio
    Colella, Giuseppe
    Amore, Roberto
    Tartaro, Gianpaolo
    DERMATOLOGIC SURGERY, 2013, 39 (12) : 1887 - 1894
  • [7] Polyacrylamide Gel Injection for Treatment of Human Immunodeficiency Virus-Associated Facial Lipoatrophy: 18 Months Follow-Up
    Rauso, Raffaele
    Freda, Nicola
    Parlato, Vincenzo
    Gherardini, Giulio
    Amore, Roberto
    Tartaro, Gianpaolo
    DERMATOLOGIC SURGERY, 2011, 37 (11) : 1584 - 1589
  • [8] Long-term safety and efficacy of poly-L-lactic acid in the treatment of HIV-related facial lipoatrophy
    Moyle, GJ
    Brown, S
    Lysakova, L
    Barton, SE
    HIV MEDICINE, 2006, 7 (03) : 181 - 185
  • [9] Long-term safety and efficacy of poly-t-lactic acid in the treatment of HIV-related facial lipoatrophy
    Moyle, G
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P133 - P133
  • [10] Long-term Efficacy and Safety of Lamivudine, Entecavir, and Tenofovir for Treatment of Hepatitis B Virus-Related Cirrhosis
    Koklu, Seyfettin
    Tuna, Yasar
    Gulsen, Murat Taner
    Demir, Mehmet
    Koksal, Aydin Seref
    Kockar, Muhammet Cem
    Aygun, Cem
    Coban, Sahin
    Ozdil, Kamil
    Ataseven, Huseyin
    Akin, Ebru
    Purnak, Tugrul
    Yuksel, Ilhami
    Ataseven, Hilmi
    Ibis, Mehmet
    Yildirim, Beytullah
    Nadir, Isilay
    Kucukazman, Metin
    Akbal, Erdem
    Yuksel, Osman
    Basar, Omer
    Alkan, Erhan
    Baykal, Ozlem
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (01) : 88 - 94
12345